Membrane raft domains and remodeling in aging brain

Biochimie

Volumn 130, Issue , 2016, Pages 178-187

  Colin, Julie ^a   Gregory Pauron, Lynn ^a   Lanhers, Marie Claire ^a   Claudepierre, Thomas ^a   Corbier, Catherine ^a   Yen, Frances T ^a   Malaplate Armand, Catherine ^a,b   Oster, Thierry ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Aging; Docosahexaenoic acid; Lipid rafts; Membrane remodeling; Neuronal membrane; Omega3 polyunsaturated fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; LIPID; NEUROTRANSMITTER; MEMBRANE LIPID; MEMBRANE PROTEIN; NEUROPROTECTIVE AGENT;

ALZHEIMER DISEASE; BRAIN FUNCTION; CELL AGING; HUMAN; MEMBRANE STRUCTURE; NERVE CELL MEMBRANE; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; REVIEW; SYNAPTIC TRANSMISSION; AGING; BIOLOGICAL MODEL; BRAIN; CHEMISTRY; DRUG EFFECTS; MEMBRANE MICRODOMAIN; METABOLISM;

AGING; ALZHEIMER DISEASE; BRAIN; DOCOSAHEXAENOIC ACIDS; HUMANS; MEMBRANE LIPIDS; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; NEUROPROTECTIVE AGENTS;

EID: 84994355401     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2016.08.014     Document Type: Review

References (162)

1. [1] Saha, S., Anilkumar, A.A., Mayor, S., GPI-anchored protein organization and dynamics at the cell surface. J. Lipid Res. 57 (2016), 159–175, 10.1194/jlr.R062885.
2. [2] Sevcsik, E., Schütz, G.J., With or without rafts? Alternative views on cell membranes. BioEssays News Rev. Mol. Cell. Dev. Biol. 38 (2016), 129–139, 10.1002/bies.201500150.
3. [3] Dietrich, C., Bagatolli, L.A., Volovyk, Z.N., Thompson, N.L., Levi, M., Jacobson, K., Gratton, E., Lipid rafts reconstituted in model membranes. Biophys. J. 80 (2001), 1417–1428, 10.1016/S0006-3495(01)76114-0.
4. [4] Milhiet, P.E., Domec, C., Giocondi, M.C., Van Mau, N., Heitz, F., Le Grimellec, C., Domain formation in models of the renal brush border membrane outer leaflet. Biophys. J. 81 (2001), 547–555.
5. [5] de Almeida, R.F.M., Loura, L.M.S., Fedorov, A., Prieto, M., Lipid rafts have different sizes depending on membrane composition: a time-resolved fluorescence resonance energy transfer study. J. Mol. Biol. 346 (2005), 1109–1120, 10.1016/j.jmb.2004.12.026.
6. [6] Pike, L.J., Lipid rafts: heterogeneity on the high seas. Biochem. J. 378 (2004), 281–292, 10.1042/BJ20031672.
7. [7] Pathak, P., London, E., The effect of membrane lipid composition on the formation of lipid ultrananodomains. Biophys. J. 109 (2015), 1630–1638, 10.1016/j.bpj.2015.08.029.
8. [8] Simons, K., Ikonen, E., Functional rafts in cell membranes. Nature 387 (1997), 569–572, 10.1038/42408.
9. [9] Pike, L.J., Rafts defined: a report on the keystone symposium on lipid rafts and cell function. J. Lipid Res. 47 (2006), 1597–1598, 10.1194/jlr.E600002-JLR200.
10. [10] Hanzal-Bayer, M.F., Hancock, J.F., Lipid rafts and membrane traffic. FEBS Lett. 581 (2007), 2098–2104, 10.1016/j.febslet.2007.03.019.
11. [11] Lamaze, C., Dujeancourt, A., Baba, T., Lo, C.G., Benmerah, A., Dautry-Varsat, A., Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. Mol. Cell 7 (2001), 661–671.
12. [12] Jahn, R., Scheller, R.H., SNAREs–engines for membrane fusion. Nat. Rev. Mol. Cell Biol. 7 (2006), 631–643, 10.1038/nrm2002.
13. [13] Salaün, C., Gould, G.W., Chamberlain, L.H., Lipid raft association of SNARE proteins regulates exocytosis in PC12 cells. J. Biol. Chem. 280 (2005), 19449–19453, 10.1074/jbc.M501923200.
14. [14] Suzuki, T., Zhang, J., Miyazawa, S., Liu, Q., Farzan, M.R., Yao, W.-D., Association of membrane rafts and postsynaptic density: proteomics, biochemical, and ultrastructural analyses. J. Neurochem. 119 (2011), 64–77, 10.1111/j.1471-4159.2011.07404.x.
15. [15] Cuddy, L.K., Winick-Ng, W., Rylett, R.J., Regulation of the high-affinity choline transporter activity and trafficking by its association with cholesterol-rich lipid rafts. J. Neurochem. 128 (2014), 725–740, 10.1111/jnc.12490.
16. [16] Magnani, F., Tate, C.G., Wynne, S., Williams, C., Haase, J., Partitioning of the serotonin transporter into lipid microdomains modulates transport of serotonin. J. Biol. Chem. 279 (2004), 38770–38778, 10.1074/jbc.M400831200.
17. [17] Sonnino, S., Aureli, M., Grassi, S., Mauri, L., Prioni, S., Prinetti, A., Lipid rafts in neurodegeneration and neuroprotection. Mol. Neurobiol. 50 (2014), 130–148, 10.1007/s12035-013-8614-4.
18. [18] Villar, V.A.M., Cuevas, S., Zheng, X., Jose, P.A., Localization and signaling of GPCRs in lipid rafts. Methods Cell Biol. 132 (2016), 3–23, 10.1016/bs.mcb.2015.11.008.
19. [19] Suzuki, S., Numakawa, T., Shimazu, K., Koshimizu, H., Hara, T., Hatanaka, H., Mei, L., Lu, B., Kojima, M., BDNF-induced recruitment of TrkB receptor into neuronal lipid rafts: roles in synaptic modulation. J. Cell Biol. 167 (2004), 1205–1215, 10.1083/jcb.200404106.
20. [20] Pereira, D.B., Chao, M.V., The tyrosine kinase Fyn determines the localization of TrkB receptors in lipid rafts. J. Neurosci. Off. J. Soc. Neurosci. 27 (2007), 4859–4869, 10.1523/JNEUROSCI.4587-06.2007.
21. [21] Pryor, S., McCaffrey, G., Young, L.R., Grimes, M.L., NGF causes TrkA to specifically attract microtubules to lipid rafts. PLoS One, 7, 2012, e35163, 10.1371/journal.pone.0035163.
22. [22] Mineo, C., Gill, G.N., Anderson, R.G., Regulated migration of epidermal growth factor receptor from caveolae. J. Biol. Chem. 274 (1999), 30636–30643.
23. [23] Vainio, S., Heino, S., Mansson, J.-E., Fredman, P., Kuismanen, E., Vaarala, O., Ikonen, E., Dynamic association of human insulin receptor with lipid rafts in cells lacking caveolae. EMBO Rep. 3 (2002), 95–100, 10.1093/embo-reports/kvf010.
24. [24] Huang, C.S., Zhou, J., Feng, A.K., Lynch, C.C., Klumperman, J., DeArmond, S.J., Mobley, W.C., Nerve growth factor signaling in caveolae-like domains at the plasma membrane. J. Biol. Chem. 274 (1999), 36707–36714.
25. [25] Li, L., Chen, H., Wang, M., Chen, F., Gao, J., Sun, S., Li, Y., Gao, D., NCAM-140 translocation into lipid rafts mediates the neuroprotective effects of GDNF. Mol. Neurobiol., 2016, 10.1007/s12035-016-9749-x.
26. [26] Sebastião, A.M., Colino-Oliveira, M., Assaife-Lopes, N., Dias, R.B., Ribeiro, J.A., Lipid rafts, synaptic transmission and plasticity: impact in age-related neurodegenerative diseases. Neuropharmacology 64 (2013), 97–107, 10.1016/j.neuropharm.2012.06.053.
27. [27] Lorent, J.H., Levental, I., Structural determinants of protein partitioning into ordered membrane domains and lipid rafts. Chem. Phys. Lipids 192 (2015), 23–32, 10.1016/j.chemphyslip.2015.07.022.
28. [28] Bishop, N.A., Lu, T., Yankner, B.A., Neural mechanisms of ageing and cognitive decline. Nature 464 (2010), 529–535, 10.1038/nature08983.
29. [29] Lee, P., Kim, J., Williams, R., Sandhir, R., Gregory, E., Brooks, W.M., Berman, N.E.J., Effects of aging on blood brain barrier and matrix metalloproteases following controlled cortical impact in mice. Exp. Neurol. 234 (2012), 50–61, 10.1016/j.expneurol.2011.12.016.
30. [30] Park, S.H., Kim, J.H., Choi, K.H., Jang, Y.J., Bae, S.S., Choi, B.T., Shin, H.K., Hypercholesterolemia accelerates amyloid β-induced cognitive deficits. Int. J. Mol. Med. 31 (2013), 577–582, 10.3892/ijmm.2013.1233.
31. [31] Beck, B., Pourié, G., Ghrelin, neuropeptide Y, and other feeding-regulatory peptides active in the hippocampus: role in learning and memory. Nutr. Rev. 71 (2013), 541–561, 10.1111/nure.12045.
32. [32] Uranga, R.M., Bruce-Keller, A.J., Morrison, C.D., Fernandez-Kim, S.O., Ebenezer, P.J., Zhang, L., Dasuri, K., Keller, J.N., Intersection between metabolic dysfunction, high fat diet consumption, and brain aging. J. Neurochem. 114 (2010), 344–361, 10.1111/j.1471-4159.2010.06803.x.
33. [33] Davidson, T.L., Hargrave, S.L., Swithers, S.E., Sample, C.H., Fu, X., Kinzig, K.P., Zheng, W., Inter-relationships among diet, obesity and hippocampal-dependent cognitive function. Neuroscience 253 (2013), 110–122, 10.1016/j.neuroscience.2013.08.044.
34. [34] Refolo, L.M., Malester, B., LaFrancois, J., Bryant-Thomas, T., Wang, R., Tint, G.S., Sambamurti, K., Duff, K., Pappolla, M.A., Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol. Dis. 7 (2000), 321–331, 10.1006/nbdi.2000.0304.
35. [35] Beilharz, J.E., Maniam, J., Morris, M.J., Short exposure to a diet rich in both fat and sugar or sugar alone impairs place, but not object recognition memory in rats. Brain. Behav. Immun. 37 (2014), 134–141, 10.1016/j.bbi.2013.11.016.
36. [36] Li, L., Cao, D., Garber, D.W., Kim, H., Fukuchi, K., Association of aortic atherosclerosis with cerebral beta-amyloidosis and learning deficits in a mouse model of Alzheimer's disease. Am. J. Pathol. 163 (2003), 2155–2164.
37. [37] Oksman, M., Iivonen, H., Hogyes, E., Amtul, Z., Penke, B., Leenders, I., Broersen, L., Lütjohann, D., Hartmann, T., Tanila, H., Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol. Dis. 23 (2006), 563–572, 10.1016/j.nbd.2006.04.013.
38. [38] Julien, C., Tremblay, C., Phivilay, A., Berthiaume, L., Emond, V., Julien, P., Calon, F., High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model. Neurobiol. Aging 31 (2010), 1516–1531, 10.1016/j.neurobiolaging.2008.08.022.
39. [39] Joseph, J.A., Villalobos-Molinas, R., Denisova, N.A., Erat, S., Strain, J., Cholesterol: a two-edged sword in brain aging. Free Radic. Biol. Med. 22 (1997), 455–462.
40. [40] Hartmann, T., Kuchenbecker, J., Grimm, M.O.W., Alzheimer's disease: the lipid connection. J. Neurochem. 103:Suppl 1 (2007), 159–170, 10.1111/j.1471-4159.2007.04715.x.
41. [41] Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., Jones, E., Alzheimer's disease. Lancet 377 (2011), 1019–1031, 10.1016/S0140-6736(10)61349-9.
42. [42] Li, G., Larson, E.B., Sonnen, J.A., Shofer, J.B., Petrie, E.C., Schantz, A., Peskind, E.R., Raskind, M.A., Breitner, J.C.S., Montine, T.J., Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology 69 (2007), 878–885, 10.1212/01.wnl.0000277657.95487.1c.
43. [43] Arvanitakis, Z., Schneider, J.A., Wilson, R.S., Bienias, J.L., Kelly, J.F., Evans, D.A., Bennett, D.A., Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology 70 (2008), 1795–1802, 10.1212/01.wnl.0000288181.00826.63.
44. [44] Panchal, M., Loeper, J., Cossec, J.-C., Perruchini, C., Lazar, A., Pompon, D., Duyckaerts, C., Enrichment of cholesterol in microdissected Alzheimer's disease senile plaques as assessed by mass spectrometry. J. Lipid Res. 51 (2010), 598–605, 10.1194/jlr.M001859.
45. [45] Shepardson, N.E., Shankar, G.M., Selkoe, D.J., Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations. Arch. Neurol. 68 (2011), 1385–1392, 10.1001/archneurol.2011.242.
46. [46] Svennerholm, L., Designation and schematic structure of gangliosides and allied glycosphingolipids. Prog. Brain Res. 101 (1994), XI–XIV, 10.1016/S0079-6123(08)61935-4.
47. [47] Marin, R., Fabelo, N., Fernández-Echevarría, C., Canerina-Amaro, A., Rodríguez-Barreto, D., Quinto-Alemany, D., Mesa-Herrera, F., Díaz, M., Lipid raft alterations in aged-associated neuropathologies. Curr. Alzheimer Res. 13 (2016), 973–984.
48. [48] Söderberg, M., Edlund, C., Kristensson, K., Dallner, G., Lipid compositions of different regions of the human brain during aging. J. Neurochem. 54 (1990), 415–423.
49. [49] Martin, M.G., Perga, S., Trovò, L., Rasola, A., Holm, P., Rantamäki, T., Harkany, T., Castrén, E., Chiara, F., Dotti, C.G., Cholesterol loss enhances TrkB signaling in hippocampal neurons aging in vitro. Mol. Biol. Cell. 19 (2008), 2101–2112, 10.1091/mbc.E07-09-0897.
50. [50] Zhang, Y., Appelkvist, E.L., Kristensson, K., Dallner, G., The lipid compositions of different regions of rat brain during development and aging. Neurobiol. Aging 17 (1996), 869–875.
51. [51] Eckert, G.P., Kirsch, C., Mueller, W.E., Differential effects of lovastatin treatment on brain cholesterol levels in normal and apoE-deficient mice. Neuroreport 12 (2001), 883–887.
52. [52] Trovò, L., Van Veldhoven, P.P., Martín, M.G., Dotti, C.G., Sphingomyelin upregulation in mature neurons contributes to TrkB activity by Rac1 endocytosis. J. Cell Sci. 124 (2011), 1308–1315, 10.1242/jcs.078766.
53. [53] Angelie, E., Bonmartin, A., Boudraa, A., Gonnaud, P.M., Mallet, J.J., Sappey-Marinier, D., Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study. AJNR Am. J. Neuroradiol. 22 (2001), 119–127.
54. [54] Ulmann, L., Mimouni, V., Roux, S., Porsolt, R., Poisson, J.P., Brain and hippocampus fatty acid composition in phospholipid classes of aged-relative cognitive deficit rats. Prostagl. Leukot. Essent. Fat. Acids 64 (2001), 189–195, 10.1054/plef.2001.0260.
55. [55] Yehuda, S., Rabinovitz, S., Carasso, R.L., Mostofsky, D.I., The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol. Aging 23 (2002), 843–853.
56. [56] Nagy, K., Nagy, V., Bertoni-Freddari, C., Nagy, I., Alterations of the synaptosomal membrane “microviscosity” in the brain cortex of rats during aging and centrophenoxine treatment. Arch. Gerontol. Geriatr. 2 (1983), 23–39.
57. [57] Marquet-de Rougé, P., Clamagirand, C., Facchinetti, P., Rose, C., Sargueil, F., Guihenneuc-Jouyaux, C., Cynober, L., Moinard, C., Allinquant, B., Citrulline diet supplementation improves specific age-related raft changes in wild-type rodent hippocampus. Age Dordr. Neth 35 (2013), 1589–1606, 10.1007/s11357-012-9462-2.
58. [58] Sodero, A.O., Trovò, L., Iannilli, F., Van Veldhoven, P., Dotti, C.G., Martin, M.G., Regulation of tyrosine kinase B activity by the Cyp46/cholesterol loss pathway in mature hippocampal neurons: relevance for neuronal survival under stress and in aging. J. Neurochem. 116 (2011), 747–755, 10.1111/j.1471-4159.2010.07079.x.
59. [59] Sodero, A.O., Weissmann, C., Ledesma, M.D., Dotti, C.G., Cellular stress from excitatory neurotransmission contributes to cholesterol loss in hippocampal neurons aging in vitro. Neurobiol. Aging 32 (2011), 1043–1053, 10.1016/j.neurobiolaging.2010.06.001.
60. [60] Segatto, M., Di Giovanni, A., Marino, M., Pallottini, V., Analysis of the protein network of cholesterol homeostasis in different brain regions: an age and sex dependent perspective. J. Cell. Physiol. 228 (2013), 1561–1567, 10.1002/jcp.24315.
61. [61] Cutler, R.G., Kelly, J., Storie, K., Pedersen, W.A., Tammara, A., Hatanpaa, K., Troncoso, J.C., Mattson, M.P., Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 2070–2075, 10.1073/pnas.0305799101.
62. [62] Palestini, P., Masserini, M., Sonnino, S., Giuliani, A., Tettamanti, G., Changes in the ceramide composition of rat forebrain gangliosides with age. J. Neurochem. 54 (1990), 230–235, 10.1111/j.1471-4159.1990.tb13305.x.
63. [63] Sacket, S.J., Chung, H.-Y., Okajima, F., Im, D.-S., Increase in sphingolipid catabolic enzyme activity during aging. Acta Pharmacol. Sin. 30 (2009), 1454–1461, 10.1038/aps.2009.136.
64. [64] Mencarelli, C., Martinez-Martinez, P., Ceramide function in the brain: when a slight tilt is enough. Cell. Mol. Life Sci. CMLS 70 (2013), 181–203, 10.1007/s00018-012-1038-x.
65. [65] Prinetti, A., Chigorno, V., Tettamanti, G., Sonnino, S., Sphingolipid-enriched membrane domains from rat cerebellar granule cells differentiated in culture. A compositional study. J. Biol. Chem. 275 (2000), 11658–11665.
66. [66] Di Pasquale, E., Fantini, J., Chahinian, H., Maresca, M., Taïeb, N., Yahi, N., Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides. J. Mol. Biol. 397 (2010), 202–218, 10.1016/j.jmb.2010.01.046.
67. [67] Yamamoto, N., Matsubara, T., Sato, T., Yanagisawa, K., Age-dependent high-density clustering of GM1 ganglioside at presynaptic neuritic terminals promotes amyloid beta-protein fibrillogenesis. Biochim. Biophys. Acta 1778 (2008), 2717–2726, 10.1016/j.bbamem.2008.07.028.
68. [68] Mansson, J.-E., Vanier, M.-T., Svennerholm, L., Changes in the fatty acid and sphingosine composition of the major gangliosides of human brain with age. J. Neurochem. 30 (1978), 273–275, 10.1111/j.1471-4159.1978.tb07064.x.
69. [69] Sonnino, S., Chigorno, V., Ganglioside molecular species containing C18- and C20-sphingosine in mammalian nervous tissues and neuronal cell cultures. Biochim. Biophys. Acta 1469 (2000), 63–77.
70. [70] Valsecchi, M., Palestini, P., Chigorno, V., Sonnino, S., Age-related changes of the ganglioside long-chain base composition in rat cerebellum. Neurochem. Int. 28 (1996), 183–187, 10.1016/0197-0186(95)00069-0.
71. [71] Dyall, S.C., Michael, G.J., Whelpton, R., Scott, A.G., Michael-Titus, A.T., Dietary enrichment with omega-3 polyunsaturated fatty acids reverses age-related decreases in the GluR2 and NR2B glutamate receptor subunits in rat forebrain. Neurobiol. Aging 28 (2007), 424–439, 10.1016/j.neurobiolaging.2006.01.002.
72. [72] McNamara, R.K., Liu, Y., Jandacek, R., Rider, T., Tso, P., The aging human orbitofrontal cortex: decreasing polyunsaturated fatty acid composition and associated increases in lipogenic gene expression and stearoyl-CoA desaturase activity. Prostagl. Leukot. Essent. Fat. Acids 78 (2008), 293–304, 10.1016/j.plefa.2008.04.001.
73. [73] Létondor, A., Buaud, B., Vaysse, C., Fonseca, L., Herrouin, C., Servat, B., Layé, S., Pallet, V., Alfos, S., Erythrocyte DHA level as a biomarker of DHA status in specific brain regions of n-3 long-chain PUFA-supplemented aged rats. Br. J. Nutr. 112 (2014), 1805–1818, 10.1017/S0007114514002529.
74. [74] Denis, I., Potier, B., Vancassel, S., Heberden, C., Lavialle, M., Omega-3 fatty acids and brain resistance to ageing and stress: body of evidence and possible mechanisms. Ageing Res. Rev. 12 (2013), 579–594, 10.1016/j.arr.2013.01.007.
75. [75] Cutuli, D., Functional and structural benefits induced by omega-3 polyunsaturated fatty acids during aging. Curr. Neuropharmacol., 14, 2016, 10.2174/1570159X14666160614091311.
76. [76] López, G.H., Ilincheta de Boschero, M.G., Castagnet, P.I., Giusto, N.M., Age-associated changes in the content and fatty acid composition of brain glycerophospholipids. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 112 (1995), 331–343.
77. [77] Favrelère, S., Stadelmann-Ingrand, S., Huguet, F., De Javel, D., Piriou, A., Tallineau, C., Durand, G., Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus. Neurobiol. Aging 21 (2000), 653–660.
78. [78] Ammar, M.R., Kassas, N., Chasserot-Golaz, S., Bader, M.-F., Vitale, N., Lipids in regulated exocytosis: what are they doing?. Front. Endocrinol., 4, 2013, 10.3389/fendo.2013.00125.
79. [79] Churchward, M.A., Rogasevskaia, T., Höfgen, J., Bau, J., Coorssen, J.R., Cholesterol facilitates the native mechanism of Ca2+-triggered membrane fusion. J. Cell Sci. 118 (2005), 4833–4848, 10.1242/jcs.02601.
80. [80] Kumar, A., Baycin-Hizal, D., Zhang, Y., Bowen, M.A., Betenbaugh, M.J., Cellular traffic cops: the interplay between lipids and proteins regulates vesicular formation, trafficking, and signaling in mammalian cells. Curr. Opin. Biotechnol. 36 (2015), 215–221, 10.1016/j.copbio.2015.09.006.
81. [81] Ledesma, M.D., Martin, M.G., Dotti, C.G., Lipid changes in the aged brain: effect on synaptic function and neuronal survival. Prog. Lipid Res. 51 (2012), 23–35, 10.1016/j.plipres.2011.11.004.
82. [82] Haque, M.E., McIntosh, T.J., Lentz, B.R., Influence of lipid composition on physical properties and peg-mediated fusion of curved and uncurved model membrane vesicles: “nature's own” fusogenic lipid bilayer. Biochem. (Mosc.) 40 (2001), 4340–4348.
83. [83] Rogasevskaia, T., Coorssen, J.R., Sphingomyelin-enriched microdomains define the efficiency of native Ca(2+)-triggered membrane fusion. J. Cell Sci. 119 (2006), 2688–2694, 10.1242/jcs.03007.
84. [84] Sonnino, S., Mauri, L., Chigorno, V., Prinetti, A., Gangliosides as components of lipid membrane domains. Glycobiology 17 (2007), 1R–13R, 10.1093/glycob/cwl052.
85. [85] Posse de Chaves, E., Sipione, S., Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction. FEBS Lett. 584 (2010), 1748–1759, 10.1016/j.febslet.2009.12.010.
86. [86] Jiang, L., Fang, J., Moore, D.S., Gogichaeva, N.V., Galeva, N.A., Michaelis, M.L., Zaidi, A., Age-associated changes in synaptic lipid raft proteins revealed by two-dimensional fluorescence difference gel electrophoresis. Neurobiol. Aging 31 (2010), 2146–2159, 10.1016/j.neurobiolaging.2008.11.005.
87. [87] Schumann, J., Leichtle, A., Thiery, J., Fuhrmann, H., Fatty acid and peptide profiles in plasma membrane and membrane rafts of PUFA supplemented RAW264.7 macrophages. PLoS One, 6, 2011, e24066, 10.1371/journal.pone.0024066.
88. [88] Volinsky, R., Kinnunen, P.K.J., Oxidized phosphatidylcholines in membrane-level cellular signaling: from biophysics to physiology and molecular pathology. FEBS J. 280 (2013), 2806–2816, 10.1111/febs.12247.
89. [89] Santos, G., Díaz, M., Torres, N.V., Lipid raft size and lipid mobility in non-raft domains increase during aging and are exacerbated in APP/PS1 mice model of Alzheimer's disease. Predictions from an agent-based mathematical model. Front. Physiol., 7, 2016, 90, 10.3389/fphys.2016.00090.
90. [90] Molander-Melin, M., Blennow, K., Bogdanovic, N., Dellheden, B., Månsson, J.-E., Fredman, P., Structural membrane alterations in Alzheimer brains found to be associated with regional disease development; increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent-resistant membrane domains. J. Neurochem. 92 (2005), 171–182, 10.1111/j.1471-4159.2004.02849.x.
91. [91] Xiong, H., Callaghan, D., Jones, A., Walker, D.G., Lue, L.-F., Beach, T.G., Sue, L.I., Woulfe, J., Xu, H., Stanimirovic, D.B., Zhang, W., Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production. Neurobiol. Dis. 29 (2008), 422–437, 10.1016/j.nbd.2007.10.005.
92. [92] Martín, V., Fabelo, N., Santpere, G., Puig, B., Marín, R., Ferrer, I., Díaz, M., Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex. J. Alzheimers Dis. JAD 19 (2010), 489–502, 10.3233/JAD-2010-1242.
93. [93] Di Paolo, G., Kim, T.-W., Linking lipids to Alzheimer's disease: cholesterol and beyond. Nat. Rev. Neurosci. 12 (2011), 284–296, 10.1038/nrn3012.
94. [94] Zhang, J., Liu, Q., Cholesterol metabolism and homeostasis in the brain. Protein Cell. 6 (2015), 254–264, 10.1007/s13238-014-0131-3.
95. [95] Xue-shan, Z., juan, P., Qi, W., Zhong, R., Li-hong, P., Zhi-han, T., Zhi-sheng, J., Gui-xue, W., Lu-shan, L., Imbalanced cholesterol metabolism in Alzheimer's disease. Clin. Chim. Acta 456 (2016), 107–114, 10.1016/j.cca.2016.02.024.
96. [96] Wang, H.-L., Wang, Y.-Y., Liu, X.-G., Kuo, S.-H., Liu, N., Song, Q.-Y., Wang, M.-W., Cholesterol, 24-Hydroxycholesterol, and 27-Hydroxycholesterol as surrogate biomarkers in cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease: a meta-analysis. J. Alzheimers Dis. JAD 51 (2016), 45–55, 10.3233/JAD-150734.
97. [97] Poirier, J., Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease. Trends Mol. Med. 9 (2003), 94–101, 10.1016/S1471-4914(03)00007-8.
98. [98] Eckhardt, M., The role and metabolism of sulfatide in the nervous system,. Mol. Neurobiol. 37 (2008), 93–103, 10.1007/s12035-008-8022-3.
99. [99] He, X., Huang, Y., Li, B., Gong, C.-X., Schuchman, E.H., Deregulation of sphingolipid metabolism in Alzheimer's disease. Neurobiol. Aging 31 (2010), 398–408, 10.1016/j.neurobiolaging.2008.05.010.
100. [100] Filippov, V., Song, M.A., Zhang, K., Vinters, H.V., Tung, S., Kirsch, W.M., Yang, J., Duerksen-Hughes, P.J., Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases. J. Alzheimers Dis. JAD 29 (2012), 537–547, 10.3233/JAD-2011-111202.
101. [101] Panchal, M., Gaudin, M., Lazar, A.N., Salvati, E., Rivals, I., Ayciriex, S., Dauphinot, L., Dargère, D., Auzeil, N., Masserini, M., Laprévote, O., Duyckaerts, C., Ceramides and sphingomyelinases in senile plaques. Neurobiol. Dis. 65 (2014), 193–201, 10.1016/j.nbd.2014.01.010.
102. [102] Couttas, T.A., Kain, N., Suchowerska, A.K., Quek, L.-E., Turner, N., Fath, T., Garner, B., Don, A.S., Loss of ceramide synthase 2 activity, necessary for myelin biosynthesis, precedes tau pathology in the cortical pathogenesis of Alzheimer's disease. Neurobiol. Aging 43 (2016), 89–100, 10.1016/j.neurobiolaging.2016.03.027.
103. [103] Crino, P.B., Ullman, M.D., Vogt, B.A., Bird, E.D., Volicer, L., Brain gangliosides in dementia of the Alzheimer type. Arch. Neurol. 46 (1989), 398–401.
104. [104] Hirano-Sakamaki, W., Sugiyama, E., Hayasaka, T., Ravid, R., Setou, M., Taki, T., Alzheimer's disease is associated with disordered localization of ganglioside GM1 molecular species in the human dentate gyrus. FEBS Lett. 589 (2015), 3611–3616, 10.1016/j.febslet.2015.09.033.
105. [105] Couttas, T.A., Kain, N., Daniels, B., Lim, X.Y., Shepherd, C., Kril, J., Pickford, R., Li, H., Garner, B., Don, A.S., Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer's disease pathogenesis. Acta Neuropathol. Commun., 2, 2014, 9, 10.1186/2051-5960-2-9.
106. [106] Plourde, M., Cunnane, S.C., Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl. Physiol. Nutr. Metab. Physiol. Appliquée Nutr. Métabolisme 32 (2007), 619–634, 10.1139/H07-034.
107. [107] Cheng, H., Wang, M., Li, J.-L., Cairns, N.J., Han, X., Specific changes of sulfatide levels in individuals with pre-clinical Alzheimer's disease: an early event in disease pathogenesis. J. Neurochem. 127 (2013), 733–738, 10.1111/jnc.12368.
108. [108] Zhu, L., Zhong, M., Elder, G.A., Sano, M., Holtzman, D.M., Gandy, S., Cardozo, C., Haroutunian, V., Robakis, N.K., Cai, D., Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer's disease pathogenesis. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 11965–11970, 10.1073/pnas.1510011112.
109. [109] Diaz, O., Berquand, A., Dubois, M., Di Agostino, S., Sette, C., Bourgoin, S., Lagarde, M., Nemoz, G., Prigent, A.-F., The mechanism of docosahexaenoic acid-induced phospholipase D activation in human lymphocytes involves exclusion of the enzyme from lipid rafts. J. Biol. Chem. 277 (2002), 39368–39378, 10.1074/jbc.M202376200.
110. [110] Fonteh, A.N., Cipolla, M., Chiang, J., Arakaki, X., Harrington, M.G., Human cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are altered in Alzheimer's disease. PLoS One, 9, 2014, 10.1371/journal.pone.0100519.
111. [111] Nakada, T., Kwee, I.L., Ellis, W.G., Membrane fatty acid composition shows delta-6-desaturase abnormalities in Alzheimer's disease. Neuroreport 1 (1990), 153–155.
112. [112] Conquer, J.A., Tierney, M.C., Zecevic, J., Bettger, W.J., Fisher, R.H., Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 35 (2000), 1305–1312.
113. [113] Thomas, J., Thomas, C.J., Radcliffe, J., Itsiopoulos, C., Omega-3 fatty acids in early prevention of inflammatory neurodegenerative disease: a focus on Alzheimer's disease. Biomed. Res. Int., 2015, 2015, 172801, 10.1155/2015/172801.
114. [114] Hooijmans, C.R., Van der Zee, C.E.E.M., Dederen, P.J., Brouwer, K.M., Reijmer, Y.D., van Groen, T., Broersen, L.M., Lütjohann, D., Heerschap, A., Kiliaan, A.J., DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice. Neurobiol. Dis. 33 (2009), 482–498, 10.1016/j.nbd.2008.12.002.
115. [115] Stenger, C., Hanse, M., Pratte, D., Mbala, M.-L., Akbar, S., Koziel, V., Escanyé, M.-C., Kriem, B., Malaplate-Armand, C., Olivier, J.-L., Oster, T., Pillot, T., Yen, F.T., Up-regulation of hepatic lipolysis stimulated lipoprotein receptor by leptin: a potential lever for controlling lipid clearance during the postprandial phase. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 24 (2010), 4218–4228, 10.1096/fj.10-160440.
116. [116] Pinçon, A., Thomas, M.H., Huguet, M., Allouche, A., Colin, J.C., Georges, A., Derrien, A., Lanhers, M.-C., Malaplate-Armand, C., Oster, T., Corbier, C., Pillot, T., Olivier, J.L., Yen, F.T., Increased susceptibility of dyslipidemic LSR+/- mice to amyloid stress is associated with changes in cortical cholesterol levels. J. Alzheimer's Dis. JAD 45 (2015), 195–204, 10.3233/JAD-142127.
117. [117] Wang, J., Wu, F., Shi, C., Substitution of membrane cholesterol with β-sitosterol promotes nonamyloidogenic cleavage of endogenous amyloid precursor protein. Neuroscience 247 (2013), 227–233, 10.1016/j.neuroscience.2013.05.022.
118. [118] Burg, V.K., Grimm, H.S., Rothhaar, T.L., Grösgen, S., Hundsdörfer, B., Haupenthal, V.J., Zimmer, V.C., Mett, J., Weingärtner, O., Laufs, U., Broersen, L.M., Tanila, H., Vanmierlo, T., Lütjohann, D., Hartmann, T., Grimm, M.O.W., Plant sterols the better cholesterol in Alzheimer's disease? A mechanistical study. J. Neurosci. Off. J. Soc. Neurosci. 33 (2013), 16072–16087, 10.1523/JNEUROSCI.1506-13.2013.
119. [119] Ariga, T., The pathogenic role of ganglioside metabolism in Alzheimer's disease-cholinergic neuron-specific gangliosides and neurogenesis. Mol. Neurobiol., 2016, 10.1007/s12035-015-9641-0.
120. [120] Nicastro, M.C., Spigolon, D., Librizzi, F., Moran, O., Ortore, M.G., Bulone, D., Biagio, P.L.S., Carrotta, R., Amyloid β-peptide insertion in liposomes containing GM1-cholesterol domains. Biophys. Chem. 208 (2016), 9–16, 10.1016/j.bpc.2015.07.010.
121. [121] Marin, R., Rojo, J.A., Fabelo, N., Fernandez, C.E., Diaz, M., Lipid raft disarrangement as a result of neuropathological progresses: a novel strategy for early diagnosis?. Neuroscience 245 (2013), 26–39, 10.1016/j.neuroscience.2013.04.025.
122. [122] Fabelo, N., Martín, V., Marín, R., Moreno, D., Ferrer, I., Díaz, M., Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions. Neurobiol. Aging 35 (2014), 1801–1812, 10.1016/j.neurobiolaging.2014.02.005.
123. [123] Vetrivel, K.S., Thinakaran, G., Membrane rafts in Alzheimer's disease beta-amyloid production. Biochim. Biophys. Acta 1801 (2010), 860–867, 10.1016/j.bbalip.2010.03.007.
124. [124] Bhattacharyya, R., Barren, C., Kovacs, D.M., Palmitoylation of amyloid precursor protein regulates amyloidogenic processing in lipid rafts. J. Neurosci. Off. J. Soc. Neurosci. 33 (2013), 11169–11183, 10.1523/JNEUROSCI.4704-12.2013.
125. [125] Das, U., Scott, D.A., Ganguly, A., Koo, E.H., Tang, Y., Roy, S., Activity-induced convergence of APP and BACE-1 in acidic microdomains via an endocytosis-dependent pathway. Neuron 79 (2013), 447–460, 10.1016/j.neuron.2013.05.035.
126. [126] Rajendran, L., Masilamani, M., Solomon, S., Tikkanen, R., Stuermer, C.A.O., Plattner, H., Illges, H., Asymmetric localization of flotillins/reggies in preassembled platforms confers inherent polarity to hematopoietic cells. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 8241–8246, 10.1073/pnas.1331629100.
127. [127] John, B.A., Meister, M., Banning, A., Tikkanen, R., Flotillins bind to the dileucine sorting motif of β-site amyloid precursor protein-cleaving enzyme 1 and influence its endosomal sorting. FEBS J. 281 (2014), 2074–2087, 10.1111/febs.12763.
128. [128] Sakurai, T., Kaneko, K., Okuno, M., Wada, K., Kashiyama, T., Shimizu, H., Akagi, T., Hashikawa, T., Nukina, N., Membrane microdomain switching: a regulatory mechanism of amyloid precursor protein processing. J. Cell Biol. 183 (2008), 339–352, 10.1083/jcb.200804075.
129. [129] Cheng, H., Vetrivel, K.S., Drisdel, R.C., Meckler, X., Gong, P., Leem, J.Y., Li, T., Carter, M., Chen, Y., Nguyen, P., Iwatsubo, T., Tomita, T., Wong, P.C., Green, W.N., Kounnas, M.Z., Thinakaran, G., S-palmitoylation of gamma-secretase subunits nicastrin and APH-1. J. Biol. Chem. 284 (2009), 1373–1384, 10.1074/jbc.M806380200.
130. [130] Grimm, M.O.W., Grösgen, S., Rothhaar, T.L., Burg, V.K., Hundsdörfer, B., Haupenthal, V.J., Friess, P., Müller, U., Fassbender, K., Riemenschneider, M., Grimm, H.S., Hartmann, T., Intracellular APP domain regulates serine-palmitoyl-CoA transferase expression and is affected in Alzheimer's disease. Int. J. Alzheimer's Dis., 2011, 2011, 695413, 10.4061/2011/695413.
131. [131] Grimm, M.O.W., Kuchenbecker, J., Rothhaar, T.L., Grösgen, S., Hundsdörfer, B., Burg, V.K., Friess, P., Müller, U., Grimm, H.S., Riemenschneider, M., Hartmann, T., Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease. J. Neurochem. 116 (2011), 916–925, 10.1111/j.1471-4159.2010.07070.x.
132. [132] Yanagisawa, K., Odaka, A., Suzuki, N., Ihara, Y., GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease. Nat. Med. 1 (1995), 1062–1066.
133. [133] Kakio, A., Nishimoto, S.I., Yanagisawa, K., Kozutsumi, Y., Matsuzaki, K., Cholesterol-dependent formation of GM1 ganglioside-bound amyloid beta-protein, an endogenous seed for Alzheimer amyloid. J. Biol. Chem. 276 (2001), 24985–24990, 10.1074/jbc.M100252200.
134. [134] Pernber, Z., Blennow, K., Bogdanovic, N., Månsson, J.-E., Blomqvist, M., Altered distribution of the gangliosides GM1 and GM2 in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 33 (2012), 174–188, 10.1159/000338181.
135. [135] Michel, V., Bakovic, M., Lipid rafts in health and disease. Biol. Cell Auspices Eur. Cell Biol. Organ 99 (2007), 129–140, 10.1042/BC20060051.
136. [136] Florent-Béchard, S., Malaplate-Armand, C., Koziel, V., Kriem, B., Olivier, J.-L., Pillot, T., Oster, T., Towards a nutritional approach for prevention of Alzheimer's disease: biochemical and cellular aspects. J. Neurol. Sci. 262 (2007), 27–36, 10.1016/j.jns.2007.06.046.
137. [137] Oster, T., Pillot, T., Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice. Biochim. Biophys. Acta 1801 (2010), 791–798, 10.1016/j.bbalip.2010.02.011.
138. [138] Slee, E.L., McLennan, P.L., Owen, A.J., Theiss, M.L., Low dietary fish-oil threshold for myocardial membrane n-3 PUFA enrichment independent of n-6 PUFA intake in rats. J. Lipid Res. 51 (2010), 1841–1848, 10.1194/jlr.M004069.
139. [139] Solfrizzi, V., Frisardi, V., Seripa, D., Logroscino, G., Imbimbo, B.P., D'Onofrio, G., Addante, F., Sancarlo, D., Cascavilla, L., Pilotto, A., Panza, F., Mediterranean diet in predementia and dementia syndromes. Curr. Alzheimer Res. 8 (2011), 520–542.
140. [140] Belkouch, M., Hachem, M., Elgot, A., Van, A.L., Picq, M., Guichardant, M., Lagarde, M., Bernoud-Hubac, N., The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease. J. Nutr. Biochem., 0, 2016, 10.1016/j.jnutbio.2016.03.002.
141. [141] Guesnet, P., Alessandri, J.-M., Docosahexaenoic acid (DHA) and the developing central nervous system (CNS) - implications for dietary recommendations. Biochimie 93 (2011), 7–12, 10.1016/j.biochi.2010.05.005.
142. [142] Stillwell, W., Wassall, S.R., Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem. Phys. Lipids 126 (2003), 1–27.
143. [143] Koenig, B.W., Strey, H.H., Gawrisch, K., Membrane lateral compressibility determined by NMR and x-ray diffraction: effect of acyl chain polyunsaturation. Biophys. J. 73 (1997), 1954–1966.
144. [144] Rawicz, W., Olbrich, K.C., McIntosh, T., Needham, D., Evans, E., Effect of chain length and unsaturation on elasticity of lipid bilayers. Biophys. J. 79 (2000), 328–339, 10.1016/S0006-3495(00)76295-3.
145. [145] Mazelova, J., Ransom, N., Astuto-Gribble, L., Wilson, M.C., Deretic, D., Syntaxin 3 and SNAP-25 pairing, regulated by omega-3 docosahexaenoic acid, controls the delivery of rhodopsin for the biogenesis of cilia-derived sensory organelles, the rod outer segments. J. Cell Sci. 122 (2009), 2003–2013, 10.1242/jcs.039982.
146. [146] Kawakita, E., Hashimoto, M., Shido, O., Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience 139 (2006), 991–997, 10.1016/j.neuroscience.2006.01.021.
147. [147] Latour, A., Grintal, B., Champeil-Potokar, G., Hennebelle, M., Lavialle, M., Dutar, P., Potier, B., Billard, J.-M., Vancassel, S., Denis, I., Omega-3 fatty acids deficiency aggravates glutamatergic synapse and astroglial aging in the rat hippocampal CA1. Aging Cell. 12 (2013), 76–84, 10.1111/acel.12026.
148. [148] Delion, S., Chalon, S., Hérault, J., Guilloteau, D., Besnard, J.C., Durand, G., Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. J. Nutr. 124 (1994), 2466–2476.
149. [149] Chalon, S., Omega-3 fatty acids and monoamine neurotransmission. Prostagl. Leukot. Essent. Fat. Acids 75 (2006), 259–269, 10.1016/j.plefa.2006.07.005.
150. [150] Kodas, E., Galineau, L., Bodard, S., Vancassel, S., Guilloteau, D., Besnard, J.-C., Chalon, S., Serotoninergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat. J. Neurochem. 89 (2004), 695–702, 10.1111/j.1471-4159.2004.02401.x.
151. [151] Aïd, S., Vancassel, S., Poumès-Ballihaut, C., Chalon, S., Guesnet, P., Lavialle, M., Effect of a diet-induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus. J. Lipid Res. 44 (2003), 1545–1551, 10.1194/jlr.M300079-JLR200.
152. [152] Li, Q., Wang, M., Tan, L., Wang, C., Ma, J., Li, N., Li, Y., Xu, G., Li, J., Docosahexaenoic acid changes lipid composition and interleukin-2 receptor signaling in membrane rafts. J. Lipid Res. 46 (2005), 1904–1913, 10.1194/jlr.M500033-JLR200.
153. [153] Schaefer, E.J., Bongard, V., Beiser, A.S., Lamon-Fava, S., Robins, S.J., Au, R., Tucker, K.L., Kyle, D.J., Wilson, P.W.F., Wolf, P.A., Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch. Neurol. 63 (2006), 1545–1550, 10.1001/archneur.63.11.1545.
154. [154] Cunnane, S.C., Chouinard-Watkins, R., Castellano, C.A., Barberger-Gateau, P., Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: can we reconcile the evidence?. Prostagl. Leukot. Essent. Fat. Acids 88 (2013), 61–70, 10.1016/j.plefa.2012.04.006.
155. [155] Cederholm, T., Palmblad, J., Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia?. Curr. Opin. Clin. Nutr. Metab. Care 13 (2010), 150–155, 10.1097/MCO.0b013e328335c40b.
156. [156] Quinn, J.F., Raman, R., Thomas, R.G., Yurko-Mauro, K., Nelson, E.B., Van Dyck, C., Galvin, J.E., Emond, J., Jack, C.R., Weiner, M., Shinto, L., Aisen, P.S., Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA J. Am. Med. Assoc. 304 (2010), 1903–1911, 10.1001/jama.2010.1510.
157. [157] Morris, M.C., Nutritional determinants of cognitive aging and dementia. Proc. Nutr. Soc. 71 (2012), 1–13, 10.1017/S0029665111003296.
158. [158] Grimm, M.O.W., Haupenthal, V.J., Mett, J., Stahlmann, C.P., Blümel, T., Mylonas, N.T., Endres, K., Grimm, H.S., Hartmann, T., Oxidized docosahexaenoic acid species and lipid peroxidation products increase amyloidogenic amyloid precursor protein processing. Neurodegener. Dis. 16 (2016), 44–54, 10.1159/000440839.
159. [159] Brzustowicz, M.R., Cherezov, V., Caffrey, M., Stillwell, W., Wassall, S.R., Molecular organization of cholesterol in polyunsaturated membranes: microdomain formation. Biophys. J. 82 (2002), 285–298, 10.1016/S0006-3495(02)75394-0.
160. [160] Neves, A.R., Nunes, C., Reis, S., Resveratrol induces ordered domains formation in biomembranes: implication for its pleiotropic action. Biochim. Biophys. Acta 1858 (2016), 12–18, 10.1016/j.bbamem.2015.10.005.
161. [161] Torres, M., Price, S.L., Fiol-Deroque, M.A., Marcilla-Etxenike, A., Ahyayauch, H., Barceló-Coblijn, G., Terés, S., Katsouri, L., Ordinas, M., López, D.J., Ibarguren, M., Goñi, F.M., Busquets, X., Vitorica, J., Sastre, M., Escribá, P.V., Membrane lipid modifications and therapeutic effects mediated by hydroxydocosahexaenoic acid on Alzheimer's disease. Biochim. Biophys. Acta 1838 (2013), 1680–1692, 10.1016/j.bbamem.2013.12.016.
162. [162] Grimm, M.O.W., Kuchenbecker, J., Grösgen, S., Burg, V.K., Hundsdörfer, B., Rothhaar, T.L., Friess, P., de Wilde, M.C., Broersen, L.M., Penke, B., Péter, M., Vígh, L., Grimm, H.S., Hartmann, T., Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms. J. Biol. Chem. 286 (2011), 14028–14039, 10.1074/jbc.M110.182329.